Predictors of drug survival of biologic therapies in psoriasis patients

Introduction We aimed to investigate the clinical, immunological, and genetic factors affecting the response to anti-TNFα (tumor necrosis factor-α) and interleukin-12/23 therapies and drug survivals. Methods A total of 180 patients were divided into two groups: 89 patients who used at least two biol...

Full description

Bibliographic Details
Main Authors: Ozge Zorlu, Emel Bülbül Başkan, Serkan Yazici, Deniz Sığırlı, Ferah Budak, Hayriye Sarıcaoğlu, Kenan Aydoğan, Lacin Cevhertas
Format: Article
Language:English
Published: Taylor & Francis Group 2022-01-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2020.1763240